Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice.

Newly synthesized benzoxazinorifamycin, KRM-1648, was studied for its in vivo anti-Mycobacterium avium complex (MAC) activities. When the MICs were determined by the agar dilution method with Middlebrook 7H11 agar medium, KRM-1648 exhibited similarly potent in vitro antimicrobial activities against...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Tomioka, H, Saito, H, Sato, K, Yamane, T, Yamashita, K, Hosoe, K, Fujii, K, Hidaka, T
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1992
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188446/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1605603/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.2.387
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!